HALO: Halozyme Therapeutics Inc insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 16 sales totaling $7.18M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-08Torley HelenCEO$520Kyes
2026-10-08Torley HelenCEO$337Kyes
2026-10-08Torley HelenCEO$1.31Myes
2026-10-08Torley HelenCEO$22Kyes
2026-10-07Torley HelenCEO$955Kyes
2026-10-07Torley HelenCEO$1.15Myes
2026-10-07Torley HelenCEO$102Kyes
2026-10-07Torley HelenCEO$23Kyes
2026-10-06Torley HelenCEO$248Kyes
2026-10-06Torley HelenCEO$656Kyes
2026-10-06Torley HelenCEO$1.09Myes
2026-10-06Torley HelenCEO$197Kyes
2026-10-01Posard Matthew L.Director$78Kyes
2026-10-01Posard Matthew L.Director$358Kyes
2026-10-01Posard Matthew L.Director$121Kyes
2026-10-01Posard Matthew L.Director$11Kyes

Institutional ownership (Q2 2026)

676 institutions reported holding $9.22B of Halozyme Therapeutics Inc on Form 13F (638 the quarter before). 100 opened a new position and 67 sold out. Shares held by institutions: +3%.

Largest holdersSharesValue
BlackRock, Inc.13,271,095$1.04B
VANGUARD CAPITAL MANAGEMENT LLC5,351,312$418.85M
VANGUARD PORTFOLIO MANAGEMENT LLC5,299,008$414.75M
STATE STREET CORP5,179,434$405.38M
Invesco Ltd.3,177,997$248.74M
MORGAN STANLEY2,832,594$221.71M
Boston Partners2,773,568$216.82M
BANK OF AMERICA CORP /DE/2,740,561$214.50M
GEODE CAPITAL MANAGEMENT, LLC2,519,951$197.28M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2,511,050$196.54M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.